DOI: 10.4103/hjum.hjum_173_25 ISSN: 0974-1291

Evaluation of the Efficacy of Raughan-e-Kaddu in Comparison with Vehicle Control Raughan-e-Kunjad in the Treatment of Insomnia: A Single-blind Randomized Controlled Trial

Shabnam Kudchi, Neha Naz Donur, Salma Khatoon, Mamadapur Saba Abdul Razzaq, Nikhat Kausar Inamdar, Khaleel Ahmed, Shaikh Nisar Ahmed Abbas
Show PDF Cite

Abstract

Background:

Insomnia is one of the most common mental disorders and is defined by trouble falling asleep, staying asleep, or waking up early, leading to dissatisfaction with sleep quality or quantity. In the present era, there is a felt need for safe and effective management options for insomnia.

Objectives:

To compare the efficacy of Raughan-e-Kaddu ( Lagenaria siceraria (Molina) Standl.) and Raughan-e-Kunjad ( Sesamum indicum L.) in the management of Sahar (insomnia) and to assess their impact on the quality of life in affected patients.

Materials and Methods:

This single-blind, randomized controlled trial included 40 participants with insomnia, aged 18–60 years. Participants were randomly assigned, 20 to either the test group or the control group, for 28 days. The test group received daily topical application of Raughan-e-Kaddu on the head, while the control group received Raughan-e-Kunjad . The primary outcome measure was the change in the Pittsburgh Sleep Quality Index (PSQI). The secondary outcome measures included changes in the Epworth Sleepiness Scale (ESS) and the Visual Analog Scale (VAS) score, assessed at baseline and at the end of the treatment period.

Results:

The VAS scores demonstrated a mean difference of 2.000 (95% confidence interval [CI]: −0.315–0.933, d = 6.428, P = 0.331). The PSQI index showed a significant mean difference of −2.700 (95% CI: −3.827 to −2.020, d = 0.921, P = 0.000). The ESS score exhibited a mean difference of −1.000 (95% CI: −2.508–1.034, d = 0.562, P = 0.315) at the conclusion of the trial.

Conclusion:

The trial suggests that Raughan-e-Kaddu may have therapeutic potential as an alternative treatment for insomnia. However, further studies with a larger sample size are recommended.

More from our Archive